ClinicalTrials.gg

Program

SAP-001

A development code.

Its studies are mostly in Gout, led by 2 companies.

Furthest: phase 2, since Jul 17, 20195 company-led studies, 2 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Shanton Pharma30 open or runningphase 2since Jul 17, 2019Oct 18, 2018none ahead
Shanton Pharma Pte.22 open or runningphase 2since Dec 12, 2022Dec 12, 2022none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Oct 18, 2018First study: phase 1 study in GoutNew to Shanton PharmaShanton Pharma · NCT03857165 · 24 enrolled · United States
  2. Jul 17, 2019Phase 2 study in GoutShanton Pharma · NCT04040816 · 40 enrolled · United States
  3. Dec 12, 2022Shanton Pharma Pte.'s first study: phase 2 study in GoutNew to Shanton Pharma Pte.Shanton Pharma Pte. · NCT05690204 · 87 enrolled · United States, Puerto Rico
  4. Aug 24, 2023Phase 1 study in GoutShanton Pharma · NCT06678581 · 70 enrolled · China
  5. Dec 4, 2024Phase 2 study in GoutShanton Pharma Pte. · NCT06729853 · 32 enrolled · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT06729853Gout · United States2Active, not recruitingShanton Pharma Pte.Jan 17, 202532
NCT06678581Gout · China1CompletedShanton PharmaDec 20, 202370
NCT05690204Gout · United States, Puerto Rico2Active, not recruitingShanton Pharma Pte.Jan 202587
NCT04040816Gout · United States2CompletedShanton PharmaAug 1, 202040
NCT03857165Gout · United States1CompletedShanton PharmaJun 2, 201924

How it is read

Names in the registry

  • “SAP-001”, 5 entries

Codes read as this program: SAP001.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.